Skip to content

Advertisement

Celebrating the 10th anniversary partnership with BMC

JECCR 10 years​​​​​​​2018 marks the 10th anniversary of the partnership between the Journal of Experimental & Clinical Cancer Research and BMC.

Over the past decade, the journal has established itself among some of the top Oncology titles in Journal Citation Reports. Click here to look back at some of the journal’s milestone achievements and best content from the past 10 years.

Featured Article: The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance

New Content ItemEpidermal growth factor receptor (EGFR) elicits a role in cell survival, differentiation, growth and tumorigenesis.  Dysregulation of this receptor has been well documented in cancer progression. It has also been well established that reactive oxygen species (ROS) have a significant involvement in the initiation and regulation of cancer. Formation of oxidative stress as a result of ROS, is thought to participate in tumorigenesis by regulating the EGFR signalling pathways.

In this review, M. Weng et al. discuss the latest evidence surrounding the interactions between ROS and the EGFR signaling pathway to help understand how modulation of ROS can control drug resistance to, and the development of, cancer.

Click here to access the full article.


Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.

Aims and scope

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.

Please click here to read more.

Articles

Most accessed articles RSS

View all articles

Meeting reports now accepted

Journal of Experimental & Clinical Cancer Research now welcomes the submission of Meeting reports to help showcase novel developments presented at meetings and conferences.

Please click here for more information on the article types accepted by Journal of Experimental & Clinical Cancer Research.

Editor-in-Chief

Mauro Castelli, Regina Elena National Cancer Institute, Italy

If you would like to contact Journal of Experimental & Clinical Cancer Research, please send an email to: 

jeccreditorial@gmail.com​​​​​​​

2017 Impact Factor

We are delighted to share with our readers that Journal of Experimental & Clinical Cancer Research has an Impact Factor of 6.217 and is currently ranked at 33 out of 222 (Q1) in the Oncology category of Journal Citation Reports (Clarivate Analytics, 2018).

We would like to extend our appreciation to all Editorial Board Members, authors and peer reviewers who have contributed to the journal and enabled this achievement.

Archival content

Journal of Experimental & Clinical Cancer Research has been publishing since 1982.  Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print.  For enquiries about previous content, please contact us on: 

jeccreditorial@gmail.com

Reviewer Acknowledgement

© Syda Productions / fotolia.com




The editorial team of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal.

Click here to visit the Reviewer acknowledgements page.

Advertisement

2017 Journal Metrics

Advertisement